Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against Haemophilus influenzae type b

Journal:

Science Advances

Published:

2026-02-27

DOI:

10.1126/sciadv.aea8116

Affiliations:

7

Authors:

10

Go to article

Institutions	Authors	Share
Jiangnan University, China	2.666667	0.27
Beijing Minhai Biological Technology Co., Ltd., China	2.000000	0.20
Tsinghua University, China	2.000000	0.20
MOE Key Laboratory of Carbohydrate Chemistry and Biotechnology, Jiangnan University, China	1.833333	0.18
Max Planck Institute of Colloids and Interfaces (MPIKG), Germany	1.000000	0.10
Wuxi School of Medicine, Jiangnan University, China	0.500000	0.05

Interested in Pharmacology and Pharmaceutical Sciences?